# Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/FBIO/journey-medical-corporation-to-participate-in-a-g-p-s-annual-virtual-healthcare--cca64eaf
Ticker: FBIO
Company: Fortress Biotech
Source: Fortress Biotech
Published: 2026-05-19 20:45 EST
Original Source URL: https://www.fortressbiotech.com/investors/news-events/press-releases/detail/744/journey-medical-corporation-to-participate-in-a-g-p-s
## Article Body
SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 5:00pm ET.

To register for the conference, visit the A.G.P. Registration Link .

About Journey Medical Corporation Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets eight branded FDA-approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com .

Company Contact: Jaclyn Jaffe (781) 652-4500 ir@jmcderm.com

Media Relations Contact: Tony Plohoros 6 Degrees (908) 591-2839 tplohoros@6degreespr.com

Source: Journey Medical Corporation
## Recent Company News
- 2026-05-19 20:45 EST — [Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference](https://biopharmsignal.com/news/FBIO/journey-medical-corporation-to-participate-in-a-g-p-s-annual-virtual-healthcare--cca64eaf) — Source: Fortress Biotech
- 2026-05-18 12:30 EST — [Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference](https://biopharmsignal.com/news/FBIO/fortress-biotech-to-participate-in-a-g-p-s-annual-virtual-healthcare-conference) — Source: Fortress Biotech
- 2026-05-14 20:10 EST — [Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights](https://biopharmsignal.com/news/FBIO/fortress-biotech-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights) — Source: Fortress Biotech
- 2026-05-13 20:01 EST — [Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights](https://biopharmsignal.com/news/FBIO/journey-medical-corporation-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights) — Source: Fortress Biotech
- 2026-05-06 20:01 EST — [Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026](https://biopharmsignal.com/news/FBIO/journey-medical-corporation-to-announce-first-quarter-2026-financial-results-on-may-13-2026) — Source: Fortress Biotech
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)